Singaporean startup develops breath test to analyze fat burning
Metanoia Sensing, a tech start-up in Singapore, has developed a breath analyzer to help people monitor their fat burning and better understand their metabolic health risks.
The non-invasive device called MetaNose uses a Micro-Electro-Mechanical System acetone sensor and proprietary signal processing algorithm to measure volatile organic compounds and analyze oxidative stress from lipid metabolism or fat burning.
According to the company, MetaNose is the “best companion for people on a ketogenic diet, exercising, or just trying to lose fat.TS metrics can help users achieve their fitness goals and monitor the effectiveness of their ketogenic diet and workout routines.
Lunit Improves Chest X-ray Reading at Radlink
South Korean medical AI company Lunit is providing its AI-powered chest X-ray analysis solution to Radlink, one of Singapore’s largest diagnostic imaging centers.
According to a press release, it will supply the Lunit INSIGHT CXR to Radlink over the next three years, improving its read accuracy and diagnostic efficiency.
Lunit said it plans to negotiate with Radlink to add its other AI solutions, including the Lunit INSIGHT MMG for mammography analysis, to its contract.
South Korea authorizes new 3D chest analysis software
Another South Korean medical device company, Medical IP, recently won approval from the South Korean Ministry of Food and Drug Safety for its chest X-ray analysis software.
The software as a medical device called TiSepX transforms chest X-rays into 3D images to analyze the condition of the lungs and adjacent organs. It can also calculate lung volume using a deep learning model.
Following its approval, Medical IP aims to expand its line of 3D chest analysis software to analyze the heart, bones and blood vessels. It is also in the process of acquiring overseas clearances and seeking partners to adopt its technology.
Chinese rehab tech maker SiYi raises $15M in Series A funding
Chinese smart rehabilitation solutions provider SiYi Intelligence has secured $15 million in a Series A funding round led by the Chengdu Bio-town Equity Investment Fund, with participation from its existing investor, Tao Capital.
The company develops rehabilitation robots for clinical and home use and for scientific research. Its portfolio consists of a robotic glove, an exoskeleton walking suit, assistive BCIs and an upper limb rehabilitation robot. Founded in 2017, SiYi now serves a customer base of approximately 3,000 clinics and 50,000 households in more than 80 countries around the world.
According to a press release, its new funds will be used to accelerate R&D of integrated solutions for neurorehabilitation and build a digital rehabilitation services platform.